PXS.AX
Price:
$0.028
Market Cap:
$20.23M
Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of oral pan-lysyl oxidase inhibitors (LOX) targeting myelofibrosis and other cancers; topical pan-LOX inhibitors targeting skin scarring after events, such ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2003-11-09
Stock Exchange
ASX
Ticker
PXS.AX
According to Pharmaxis Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 13.09M. This represents a change of -45.37% compared to the average of 23.96M of the last 4 quarters.
The mean historical Enterprise Value of Pharmaxis Ltd over the last ten years is 39.04M. The current 13.09M Enterprise Value has changed 3.25% with respect to the historical average. Over the past ten years (40 quarters), PXS.AX's Enterprise Value was at its highest in in the March 2018 quarter at 281.97M. The Enterprise Value was at its lowest in in the September 2018 quarter at -46758000.00.
Average
39.04M
Median
28.55M
Minimum
-2252807.41
Maximum
76.29M
Discovering the peaks and valleys of Pharmaxis Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 105.31%
Maximum Annual Enterprise Value = 76.29M
Minimum Annual Increase = -1216.60%
Minimum Annual Enterprise Value = -2252807.41
Year | Enterprise Value | Change |
---|---|---|
2023 | 24.94M | -21.92% |
2022 | 31.94M | 33.88% |
2021 | 23.86M | 22.71% |
2020 | 19.44M | -73.20% |
2019 | 72.55M | -4.90% |
2018 | 76.29M | 14.17% |
2017 | 66.82M | 29.39% |
2016 | 51.65M | 105.31% |
2015 | 25.15M | -1216.60% |
2014 | -2252807.41 | -73.89% |
The current Enterprise Value of Pharmaxis Ltd (PXS.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
26.91M
5-year avg
34.55M
10-year avg
39.04M
Pharmaxis Ltd’s Enterprise Value is less than Starpharma Holdings Limited (26.16M), less than Acrux Limited (14.03M), less than Bionomics Limited (1.44B), less than PYC Therapeutics Limited (531.50M), less than Neuren Pharmaceuticals Limited (1.52B),
Company | Enterprise Value | Market cap |
---|---|---|
26.16M | $45.99M | |
14.03M | $13.27M | |
1.44B | $13.22M | |
531.50M | $597.26M | |
1.52B | $1.52B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmaxis Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharmaxis Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pharmaxis Ltd's Enterprise Value?
What is the highest Enterprise Value for Pharmaxis Ltd (PXS.AX)?
What is the 3-year average Enterprise Value for Pharmaxis Ltd (PXS.AX)?
What is the 5-year average Enterprise Value for Pharmaxis Ltd (PXS.AX)?
How does the current Enterprise Value for Pharmaxis Ltd (PXS.AX) compare to its historical average?